17 June 2020

Individualizing communications: from concept to impact

Individualizing communications

Champion sponsor of the Annual Meeting

Reported by Devorah Weinstock

Speakers

  • Denise Bonen, Senior Scientific Director, Complete HealthVizion
  • Heather Abourjaily, Head of Global Scientific Communications – Pipeline, Vertex Pharmaceuticals
  • David Hogben, Director, Region USA & Global Multichannel, Complete HealthVizion

Who doesn’t enjoy a good story? Stories communicated well can share meaningful content in an impactful way, and most people can relate by remembering poignant stories heard in their youth.

The speakers in this session highlighted elements of effective storytelling in the current medical publications landscape. Effective elements include weaving together a conflict, action, and resolution.

The speakers highlighted the implications for current medical communications. There is conflict in the medical publications space. The shift in healthcare towards precision medicine is disrupting the way audiences think and relate to medical and scientific communications. Vast amounts of data are expected to be rapidly and accurately communicated and disseminated to target audiences. How can this be done?

The key action to resolving this conflict is to individualize medical publications in order to connect with your audience on a human level. Moreover, for a story to resonate it is critical to understand a target audience’s needs, preferences, and learning styles. Individualizing publications to target audiences follows the 2020 trend of individualizing medicine to patients.

Finally, once the communication conflict is resolved, positive changes in clinical decision-making, behaviors, and practices can happen, enabling a truly meaningful difference in the lives of patients. 

17 June 2020

Editor's panel: I'm an Editor – ask me anything!

Ask me anything

Champion sponsor of the Annual Meeting

Reported by Devorah Weinstock

Speakers

  • Caroline Halford, Chief Publishing Officer, PLOS
  • Alan Moore, Digital Publishing Manager, Adis | Springer Healthcare Ltd
  • Shawn Morton, Senior Editorial Director, Health Sciences, Wiley
  • Niamh O’Connor, Chief Publishing Officer, PLOS

This session with journal editors was packed with rich and relevant content. Questions asked of the editors spanned a wide range of topics including open access, predatory publishing, digital publications, and the effect of COVID-19 on medical publications.

A question on ethical considerations in medical publications brought out a thought-provoking discussion. Caroline Halford mentioned that GPP3, ICJME, and COPE have fantastic guidelines for authors to follow. These guidelines help authors adhere to the highest ethical standards in the publication process.

Some common pitfalls for authors were discussed. For example, all clinical data should be published where possible.

Additionally, authors should not get discouraged if a high impact journal rejects their manuscript, rather they should remain realistic and submit to lower impact journals, which will gladly publish their article.

Another potential pitfall is the misconception that all trials need ethical approval from an institutional review board. This level of ethical approval only applies to clinical trials involving human subjects. Market access studies or surveys on wearable devices are not of this nature, and therefore do not require the same level of ethical approval.

The session ended with many questions for the panelists and a great deal of sound advice for future manuscript submissions!

5 June 2020

A message from Oxford PharmaGenesis

We are watching, with you, the events that are unfolding in the USA. At Oxford PharmaGenesis, we value diversity of culture and of opinion in our aspiration to uphold an environment in which employees can be themselves and express their views. This ideal is woven into our company’s philosophy, which speaks to maintaining a workplace that is both supportive and diverse.

Continue reading

5 June 2020

How was Virtual ASCO 2020?

We were excited to participate in the first ever ASCO virtual annual meeting last week. Although we missed the in-person interactions, we did not miss the travelling, and it was great to hear about all the exciting developments in cancer research from the comfort of our own homes!

Continue reading
1 2 3 4 5 30